叙利亚晚期乳腺癌患者的临床病理特征,治疗模式和生存结果

Muhammad Muhammad1,2, Mousa Alali1,2, Maher Saifo1,2

  • 1Faculty of Medicine, Damascus University, Damascus, Syria.

Frontiers in oncology
|September 27, 2024
PubMed
概括

临床病理学因素显著影响晚期乳腺癌 (ABC) 存活率. 与化疗相比,内分泌疗法在HR-阳性/HER2-阴性ABC中显示出更高的无进展生存率.